CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)

Clinical trial NCT06420089 · RECRUITING

Trial details

NCT number: NCT06420089
Sponsor: Vittoria Biotherapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

T Cell Non-Hodgkin Lymphoma

Start date: 2024-10-04
Primary completion: 2028-08-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.